
Myeloma UK, the only organisation in the UK dealing exclusively with myeloma, will have a new CEO in place from …

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

